Results 21 to 30 of about 277,999 (264)

Changes in metamorphopsia after the treat-and-extend regimen of anti-VEGF therapy for macular edema associated with branch retinal vein occlusion.

open access: yesPLoS ONE, 2020
This study aims to investigate the changes in metamorphopsia after administering the treat-and-extend regimen of anti-vascular endothelial growth factor therapy for branch retinal vein occlusion-associated macular edema.
Kenichiro Mori   +10 more
doaj   +1 more source

Idiopathic thrombocytopenic purpura and its fundus features in a patient with diabetes mellitus

open access: yesIndian Journal of Ophthalmology, 2020
In this case report, we present a patient with thrombocytopenia secondary to idiopathic thrombocytopenic purpura (ITP), whose fundus appearance had features of diabetic retinopathy with macular edema.
R Rajesh   +2 more
doaj   +1 more source

Peripheral retinal leakage in POEMS syndrome

open access: yesInternational Journal of Retina and Vitreous, 2021
Background POEMS (polyneuropathy, organomegaly, endocrinopathy, myeloma protein, skin changes) syndrome is a rare blood disorder with multi-system involvement. The cause is unknown.
Andrew Rising Carey, Praveen Jeyaseelan
doaj   +1 more source

Prevalence and Risk Factors of Pedal Edema in Chronic Leg Edema

open access: yesAnnals of Vascular Surgery
This study aimed to determine the prevalence and underlying causes of pedal edema (PE) in legs affected by chronic edema.A total of 705 legs with chronic edema, defined as persistent leg edema lasting for > 3 months, were examined in 411 patients who visited our clinic between April 2009 and March 2024. Patients with known systemic edematous conditions
Kotaro, Suehiro   +9 more
openaire   +2 more sources

Anti-vascular endothelial growth factor therapy for diabetic macular edema

open access: yesTherapeutic Advances in Endocrinology and Metabolism, 2013
Diabetes mellitus is a serious health problem that affects over 350 million individuals worldwide. Diabetic retinopathy (DR), which is the most common microvascular complication of diabetes, is the leading cause of new cases of blindness in working-aged ...
David S. Boyer   +3 more
doaj   +1 more source

The role of anti-vascular endothelial growth factor in diabetic macular edema

open access: yesMedicina Universitaria, 2022
The continuous growing number of diabetic patients has caused a stable increase in the global prevalence of diabetes mellitus. One of the most common complications caused by diabetes is diabetic macular edema (DME).
Giovani Faustine, Ani Retno-Prijanti
doaj   +1 more source

Personalized Zebrafish Models for Fusion‐Positive Pediatric Sarcomas

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Clinical sequencing efforts have revolutionized our approaches to categorizing pediatric cancers in real time. This has dramatically improved our ability to profile pediatric tumors, identify actionable vulnerabilities, and influence clinical care.
Lisa H. Hall   +2 more
wiley   +1 more source

T2* Magnetic Resonance Imaging Uncovers Hemosiderin Burden in Pediatric Hemophilia: A Call for Sensitive Imaging Biomarkers

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hemophilic arthropathy remains the leading morbidity in hemophilia despite modern prophylaxis, and early joint damage may be missed by routine exams. This study explored T2* MRI as a noninvasive biomarker of hemosiderin deposition in pediatric hemophilia.
Jessica Garcia   +6 more
wiley   +1 more source

Diabetic macular edema: it is more than just VEGF [version 1; referees: 2 approved]

open access: yesF1000Research, 2016
Diabetic macular edema is a serious visual complication of diabetic retinopathy. This article reviews the history of previous and current therapies, including laser therapy, anti-vascular endothelial growth factor agents, and corticosteroids, that have ...
Michael A. Singer   +4 more
doaj   +1 more source

The adenylyl cyclase activity of anthrax edema factor [PDF]

open access: yesMolecular Aspects of Medicine, 2009
Bacillus anthracis, the etiologic agent for anthrax, secretes edema factor (EF) to disrupt intracellular signaling pathways. Upon translocation into host cells and association with a calcium sensor, calmodulin (CaM), EF becomes a highly active adenylyl cyclase (AC) that raises the intracellular concentration of cyclic AMP (cAMP). Growing evidence shows
Wei-Jen, Tang, Qing, Guo
openaire   +2 more sources

Home - About - Disclaimer - Privacy